Cargando…
Metformin and the risk of dementia based on an analysis of 396,332 participants
BACKGROUND: AMPK has attracted widespread interest as a potential therapeutic target for age-related diseases, given its key role in controlling energy homeostasis. Metformin (Met) has historically been used to treat Type 2 diabetes and has been shown to counteract age-related diseases. However, stu...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277541/ https://www.ncbi.nlm.nih.gov/pubmed/35847477 http://dx.doi.org/10.1177/20406223221109454 |